MO
Matt O'Brien Piper Sandler Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
43
Avg Return
Past Year
Past Year
1%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
83.7%
Neutral
16.3%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Health Information Services
Medical Devices
Medical Distribution
Medical Instruments & Supplies
Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
---|---|---|---|---|---|---|---|---|
Overweight
Maintained
| $22 |
25%
upside
| 2 | -11% |
0
%
| 10 Oct ‘25 10 days ago |
|
|
Overweight
Initiated
| $38 |
8%
upside
| 1 | +11% |
0
%
| 2 Sep ‘25 1 month ago |
|
|
Overweight
Initiated
| $18 |
44%
upside
| 1 | -1.7% |
0
%
| 25 Aug ‘25 1 month ago |
|
|
Overweight
Initiated
| $18 |
25%
upside
| 1 | +6% |
0
%
| 18 Aug ‘25 2 months ago |
|
|
Overweight
Maintained
| $55 |
58%
upside
| 1 | -24% |
0
%
| 7 Aug ‘25 2 months ago |
|
|
Neutral
Downgraded
| $14 |
10%
downside
| 2 | -15% |
0
%
| 7 Aug ‘25 2 months ago |
|
|
Overweight
Maintained
| $100 |
46%
upside
| 2 | +1.8% |
0
%
| 31 Jul ‘25 2 months ago |
|
|
Overweight
Maintained
| $68 |
42%
upside
| 1 | -4.7% |
0
%
| 31 Jul ‘25 2 months ago |
|
|
Overweight
Reiterated
| $145 |
21%
upside
| 6 | +2.4% |
0
%
| 4 Jun ‘25 4 months ago |
|
|
Overweight
Maintained
| $80 |
30%
upside
| 2 | -9.6% |
0
%
| 9 May ‘25 5 months ago |
|
|
Overweight
Maintained
| $12 |
19%
upside
| 3 | +9.6% |
0
%
| 9 May ‘25 5 months ago |
|
|
Overweight
Reiterated
| $15 |
3%
downside
| 2 | +20% |
0
%
| 2 May ‘25 5 months ago |
|
|
Overweight
Maintained
| $165 |
108%
upside
| 2 | -28% |
0
%
| 15 Apr ‘25 6 months ago |
|
|
Overweight
Initiated
| $27 |
1%
upside
| 1 | +14% |
0
%
| 31 Mar ‘25 6 months ago |
|
|
Neutral
Downgraded
| $2 |
35%
upside
| 2 | -22% |
0
%
| 21 Mar ‘25 7 months ago |
|
|
Neutral
Maintained
| $3.50 |
25%
downside
| 2 | – |
–
| 6 Mar ‘25 7 months ago |
|
|
Neutral
Downgraded
| $140 |
7%
upside
| 1 | – |
–
| 28 Feb ‘25 7 months ago |
|
|
Overweight
Initiated
| $26 |
28%
upside
| 1 | -1.7% |
0
%
| 24 Feb ‘25 7 months ago |
|
|
Overweight
Maintained
| $310 |
5%
downside
| 1 | +13% |
0
%
| 21 Feb ‘25 8 months ago |
|
|
Overweight
Reiterated
| $330 |
33%
upside
| 3 | +6% |
0
%
| 19 Feb ‘25 8 months ago |
|
|
Overweight
Maintained
| $50 |
33%
upside
| 1 | -11% |
0
%
| 13 Feb ‘25 8 months ago |
|
|
Neutral
Maintained
| $16 |
37%
downside
| 1 | – |
–
| 12 Feb ‘25 8 months ago |
|
|
Overweight
Maintained
| $115 |
14%
upside
| 1 | -1.8% |
0
%
| 3 Feb ‘25 8 months ago |
|
|
Neutral
Reiterated
| $12 |
199%
upside
| 1 | – |
–
| 8 Nov ‘24 11 months ago |
|
|
Overweight
Reiterated
| $420 |
10%
upside
| 1 | +6.2% |
0
%
| 30 Oct ‘24 11 months ago |
|